4-Thiazolidinone derivatives as potent antimicrobial agents: microwave-assisted synthesis, biological evaluation and docking studies

被引:45
作者
Pitta, Eleni [1 ]
Tsolaki, Evangelia [1 ]
Geronikaki, Athina [1 ]
Petrovic, Jovana [2 ]
Glamoclija, Jasmina [2 ]
Sokovic, Marina [2 ]
Crespan, Emmanuele [3 ]
Maga, Giovanni [3 ]
Bhunia, Shome S. [4 ,5 ]
Saxena, Anil K. [4 ,5 ]
机构
[1] Aristotle Univ Thessaloniki, Sch Pharm, Dept Med Chem, Thessaloniki 54124, Greece
[2] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Plant Physiol, Mycol Lab, Belgrade 11000, Serbia
[3] IGM CNR, Inst Mol Genet, I-27100 Pavia, Italy
[4] Acad Sci & Innovat Res, New Delhi 110001, India
[5] CSIR, Cent Drug Res Inst, Med & Proc Chem Div, Lucknow 226001, Uttar Pradesh, India
关键词
LOCAL-ANESTHETIC ACTIVITY; ADAMANTANE DERIVATIVES; THIAZOLIDINONE DERIVATIVES; INHIBITORS; EPIDEMIOLOGY; INFECTIONS; DESIGN; HIV;
D O I
10.1039/c4md00399c
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As a part of our ongoing research in the development of new antimicrobials, herein, we report the synthesis of ten compounds which combine three bioactive moieties: thiazole, adamantane and 4-thiazolidinone. Evaluation of their antibacterial activity revealed that the newly synthesized compounds exhibited remarkable growth inhibition of a wide spectrum of Gram-positive bacteria, Gram-negative bacteria and fungi. The majority of the compounds displayed greater antibacterial activity than the reference drugs (ampicillin and streptomycin), while the antifungal activity was significantly higher than that of the reference drugs bifonazole and ketoconazole. Additionally, the title compounds were screened for HIV-1 reverse transcriptase inhibitory activity, showing no significant activity. Moreover, docking studies were performed in order to explore possible binding modes at the MurB protein of S. aureus.
引用
收藏
页码:319 / 326
页数:8
相关论文
共 61 条
[1]  
Ablordeppey SY, 1999, CURR MED CHEM, V6, P1151
[2]  
[Anonymous], 2001, DISC STUD VERS 2 0
[3]  
[Anonymous], 2009, LIGPREP VERS 2 3
[4]  
[Anonymous], 2009, GLID VERS 5 5
[5]   Recent advances in the treatment of infections due to resistant Staphylococcus aureus [J].
Anstead, GM ;
Owens, AD .
CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (06) :549-555
[6]   Novel inhibitors of an emerging target in Mycobacterium tuberculosis;: Substituted thiazolidinones as inhibitors of dTDP-rhamnose synthesis [J].
Babaoglu, K ;
Page, MA ;
Jones, VC ;
McNeil, MR ;
Dong, CJ ;
Naismith, JH ;
Lee, RE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) :3227-3230
[7]   Synthesis and anti-HIV studies of 2-and 3-adamantyl-substituted thiazolidin-4-ones [J].
Balzarini, Jan ;
Orzeszko-Krzesinska, Barbara ;
Maurin, Jan K. ;
Orzeszko, Andrzej .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (01) :303-311
[8]   Solid-phase synthesis of novel inhibitors of farnesyl transferase [J].
Barber, AM ;
Hardcastle, IR ;
Rowlands, MG ;
Nutley, BP ;
Marriott, JH ;
Jarman, M .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (04) :623-626
[9]  
Barreca Maria Letizia, 2003, Farmaco (Lausanne), V58, P259, DOI 10.1016/S0014-827X(03)00024-7
[10]  
BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247